Accel

Quick links to important sections

Accel

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Accel

Property Description
Active Ingredient Amlodipine (as besylate salt)
Form Tablet (oral dosage form)
Pharmacological Class Calcium Channel Blocker (CCB)
General Purpose Managing elevated blood pressure; easing chronic angina
Origin Synthetic chemical compound

What Type of Medicine is Accel (Amlodipine)?

Accel is a prescription-only medication that falls into the category of cardiovascular drugs, containing the active ingredient Amlodipine. This substance belongs to the major pharmacological class of Calcium Channel Blockers (CCBs), specifically identified as a Dihydropyridine agent. Amlodipine maintains a profile as a long-acting calcium channel antagonist. The compound is a purely synthetic entity, distinguishing it from substances derived from natural sources, and is clinically recognized for its sustained twenty-four-hour action profile, which contributes to its broad usage.


Form, Composition, and General Benefit

Accel is consistently manufactured for oral dosage form, typically administered to patients as a tablet. Its composition is that of a single-entity product (monotherapy), combining Amlodipine besylate with essential inactive pharmaceutical excipients required for tablet formation. The drug's high-level purpose stems from its ability to cause peripheral vasodilation—the widening of blood vessels—which results in a beneficial reduction of peripheral vascular resistance. This action is key to its role in managing hypertension, a typical use scenario for adults. By widening blood vessels, the medication makes it easier for the heart to pump blood, translating into the general benefit of helping to consistently lower elevated blood pressure and ensuring adequate blood supply to the heart muscle, offering relief for chronic stable chest discomfort.

Regulatory References

  1. MedlinePlus notes

What side effects are possible with Accel?

Possible Side Effects and Safety Information

Official regulatory documents classify the possible adverse reactions of Accel (Amlodipine) according to their frequency, providing a formal structure for the safety profile. The most frequently observed reaction is oedema (swelling), typically of the ankles, which is categorized as very common. Other common effects often reported include headache, dizziness, fatigue, nausea, abdominal pain, palpitations, and flushing.

Adverse reactions are grouped by the affected organ system, with documented effects across the nervous system (e.g., somnolence, tremor), cardiovascular system (e.g., hypotension, arrhythmia), and gastrointestinal system. Some reactions, such as headache and dizziness, are noted as being more common at the beginning of the treatment.

Less frequently reported but clinically significant reactions are classified as very rare. These serious adverse reactions documented in regulatory labeling include myocardial infarction (heart attack), hepatitis, pancreatitis, and severe dermatological conditions such as Stevens-Johnson syndrome and angioedema.

Safety statements also address specific patient populations. Older adults and individuals with hepatic impairment are noted for potentially having decreased clearance of the medicine. Furthermore, safety limitations exist, including a contraindication for use in individuals with known sensitivity to amlodipine, severe hypotension, and conditions such as high-grade aortic stenosis.

Overdose and Emergency Response

Accel Overdose and When to Seek Help

Accel (methylphenidate) is a central nervous system stimulant, and an overdose can lead to a state of excessive stimulation, which is a medical emergency. Taking more than the prescribed amount, whether accidentally or intentionally, can result in serious, potentially life-threatening complications.

Overdose symptoms are often related to over-stimulation of the nervous and cardiovascular systems. Signs can include extreme restlessness, agitation, and tremors. Cardiovascular effects may involve palpitations, dangerously fast or irregular heartbeats (tachycardia, arrhythmias), and high blood pressure (hypertension).

Severe manifestations can involve toxic psychosis, hallucinations, delirium, confusion, headache, sweating (hyperhidrosis), and very high fever (hyperpyrexia). In critical cases, an overdose may lead to convulsions, coma, and muscle breakdown (rhabdomyolysis). Gastrointestinal symptoms such as nausea, vomiting, and diarrhea may also occur.

If you suspect an overdose on Accel, immediately contact emergency medical services or a poison control center. Treatment for an overdose is primarily supportive and often involves managing symptoms like agitation and heart rate in a hospital setting. Do not attempt to induce vomiting. It is crucial to seek professional help without delay, as immediate care is necessary to manage symptoms and prevent severe outcomes.

Therapeutic Uses of Accel

Accel (Amlodipine) is commonly used in cardiovascular disease management, which supports the circulatory system and helps ease symptomatic discomfort. This medication is applied across core therapeutic areas, including the use for managing sustained high blood pressure and easing recurrent chest discomfort.


Sustained Use for High Blood Pressure

This domain covers the primary use of Accel, applied in addressing sustained and chronic elevation of arterial pressure (hypertension). It is relevant in clinical settings that involve chronic, persistent symptoms related to systemic imbalance. The main benefit is that it helps maintain a sense of stability when symptoms are more noticeable, and contributes to easing the overall symptom load related to elevated pressure.

“This medication is considered relevant for patients requiring long-term support to address symptoms related to chronic cardiovascular strain.”


Easing Recurrent Chest Discomfort (Angina)

Accel also provides supportive relief for patients experiencing recurrent chest discomfort or pressure associated with angina pectoris. It is used for managing episodes of chronic stable angina and vasospastic angina. The main benefit is that it may assist with easing distress related to the frequency of anginal episodes, which supports the patient during difficult episodes and supports general well-being during symptomatic phases.

Quick Fact: Easing Angina Symptoms

Accel is commonly used to help with symptoms that interfere with daily functioning, specifically for managing episodes of recurrent chest discomfort and supporting patients during temporary symptomatic strain.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Accel (Amlodipine) eligibility rules are defined by government regulatory agencies and strictly classify which patient populations are permitted, restricted, or prohibited from use.

Eligibility Scope

Population Status Regulatory Rule Condition-Specific Rule
Populations Allowed Adults are the standard approved population for all indications. Pediatric use is limited to hypertension in patients aged 6 to 17 years. Use is generally allowed in renal impairment at normal doses.
Populations Contraindicated Known hypersensitivity to Amlodipine or other dihydropyridine compounds. Some national monographs list breastfeeding as a contraindication. Use is contraindicated in severe hypotension and cardiogenic shock.

Eligibility-Related Restrictions

  • Age-Related Use: Use in children under 6 years old is not established by regulatory bodies, and use is not recommended. Older adults require a cautious, low initial dose due to potential decreased clearance.
  • Organ Impairment: Patients with hepatic impairment require cautious dose selection, starting at the lowest possible dose, as clearance is decreased.
  • Cardiovascular Conditions: Patients with severe aortic stenosis or severe obstructive coronary artery disease require special caution due to the documented potential for worsening cardiac status upon initiation or dose increase.
  • Pregnancy/Lactation: Safety in human pregnancy is not established; use is conditional on benefit justifying risk. Breastfeeding must be discontinued while on this medication.

What should I know about interactions with other medicines?

Accel Interactions with other medicines and products

This section outlines the clinically significant drug-drug interactions, as documented in official regulatory labeling for products marketed under the name Accel (specifically referencing formulations containing Citalopram, Candesartan, and Entecavir).

Contraindicated Combinations

Certain combinations are explicitly restricted due to significant risk:

  • Monoamine Oxidase Inhibitors (MAOIs): Co-administration with MAOIs (such as phenelzine, tranylcypromine, moclobemide, or selegiline) is prohibited, including use in patients who have recently taken an MAOI. This restriction also applies to Linezolid (an antibiotic) and intravenous Methylene Blue, both of which possess MAOI properties.
  • Pimozide: Concomitant use with this medication is also restricted.
  • Aliskiren: The combination of Accel-Candesartan with aliskiren (a blood pressure-lowering medicine) is explicitly contraindicated in patients with diabetes or kidney disease.

Other Clinically Significant Interactions

Interacting Product Category Official Regulatory Constraint
Drugs Affecting Platelets (e.g., other SSRIs) May increase the chance of a bleeding event (pharmacodynamic interaction).
Medicines Eliminated by the Kidneys May interact with Accel-Entecavir (pharmacokinetic interaction).

These mandated restrictions define the limits for co-prescribing based on the potential for enhanced side-effects or altered drug exposure, requiring careful adherence to regulatory guidelines.

Mechanism of Action

Accel (Amlodipine) operates through a targeted mechanism focused on regulating the contraction of blood vessel walls, a process fundamental to controlling blood flow dynamics.

Selective L-Type Calcium Channel Blockade

The core mechanism involves Accel acting as a selective antagonist of the voltage-dependent L-type calcium channels (CaV 1.2) found in the walls of the arteries and arterioles. This action directly prevents the entry of extracellular calcium ions ( Ca^2+) into the smooth muscle cells, which is the necessary signal for the cell's excitation-contraction coupling sequence.

Modulation of Vascular Smooth Muscle Tone

By inhibiting the calcium signal, the drug interrupts the sequence necessary for muscle shortening, resulting in the attenuation of vascular smooth muscle tone (vasodilation). This systemic vasodilation directly leads to a reduction in peripheral vascular resistance—the mechanical pressure the heart must overcome—and also causes dilation within the coronary arteries. This dual effect is the basis for the drug's physiological changes in the circulatory system.

Kinetic Profile and Functional Constraints

The drug's sustained action is a result of its slow binding and unbinding kinetics at the calcium channel site, ensuring consistent modulation of vascular tone. However, the physiological consequences of afterload reduction may be limited in conditions where the heart's mechanical capacity is severely fixed.

Dosage and Administration Information

How Accel (Amlodipine) is Used

The principles for using Accel focus on a standardized, long-term administration pattern. The route is oral administration, using the tablet formulation. Administration is based on a once-daily schedule, consistent with the drug's long-acting profile, and may be taken with or without food. To promote consistent use, it is recommended that the medicine be taken at the same time each day.


Standard Dosing and Adjustment Rules

The standard starting dose for adults is 5 mg once daily. The dose is adjusted based on patient response, but the maximum daily dose for an adult must not exceed 10 mg. Dose modification involves a cautious approach, where any increase is typically separated by a minimum interval of 7 to 14 days. This waiting period ensures the patient has reached a stable level before the next change is considered.


Population-Specific Usage

A lower initial dose of 2.5 mg once daily is specifically designated for use in older adults or patients with known hepatic impairment. This is an adjustment made due to potentially altered clearance rates in these groups. In contrast, no initial dose change is typically necessary for patients with renal impairment. For children aged 6 to 17 years being treated for hypertension, the maximum recommended daily dose is limited to 5 mg once daily. If a daily dose is missed, the patient should take it as soon as it is remembered, unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped.

Recent Clinical Evidence

Research evidence / Overview of Studies for Accel (Amlodipine)

The available research for Accel (Amlodipine) includes large-scale clinical investigations, such as numerous Randomized Controlled Trials (RCTs) and comprehensive meta-analyses that consolidate findings across multiple studies. This overview describes what the research has explored and what the current scientific literature indicates, without providing personal medical advice or usage instructions.


Evidence for Use in Managing Elevated Blood Pressure (Hypertension)

Research examining the use of Accel for chronic elevated blood pressure (hypertension) has often involved large, long-term Randomized Controlled Trials. These studies were designed to evaluate whether the use of the medicine was associated with changes in systolic and diastolic blood pressure over time. Trials also monitored cardiovascular events, such as stroke, myocardial infarction (heart attack), and the need for coronary revascularization procedures, primarily in adult populations with chronic hypertension and cardiovascular risk.

Studies reported measurements of blood pressure change observed throughout the study periods. Data from these large clinical trials described patterns of lower measured rates for several predefined cardiovascular events observed over multiple years when Amlodipine-based regimens were studied in high-risk patients.

Evidence for Use in Easing Recurrent Chest Discomfort (Angina Pectoris)

For patients experiencing recurrent chest discomfort or pressure related to angina, the evidence base includes controlled clinical trials. These studies examined how the medicine related to a patient's symptom patterns. Outcomes monitored included the observed frequency of anginal episodes and functional measurements like exercise tolerance.

Studies reported measurements that showed a decrease in the frequency of anginal episodes and a corresponding reduction in the use of rescue medication over short-term observation periods. Trial data described patterns of use that were associated with lower measured rates of hospitalization specifically for unstable angina. Evidence from these symptomatic trials is limited concerning the drug's effect on the overall progression of coronary atherosclerosis or rates of all-cause mortality over shorter follow-up periods.


What is Still Uncertain About the Research for Accel

Scientific review identifies several areas where data remain limited or insufficient within the overall research landscape. Research reported an inconsistent data pattern when measuring the incidence of heart failure within the Amlodipine-based regimens compared to specific non-calcium channel blocker regimens. Furthermore, for children, studies are characterized by their short-term follow-up, meaning there is a documented lack of long-term data concerning the medicine's impact on cardiovascular outcomes and potential effects on growth and development. Overall, evidence quality varies across studies, and findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study

Frequently Asked Questions (FAQ)

Common questions about Accel (FAQ)


Q: How quickly does Accel usually start working?

Studies on the body’s processing of Accel indicate that blood pressure may begin to decrease gradually within hours (often noted between four and eight hours) following the first dose. However, the full, stable therapeutic effect of the medication typically takes several weeks of consistent, once-daily use to be established.


Q: How long do the effects of Accel typically last?

Accel is designed as a long-acting medicine, and its consistent therapeutic effect is sustained for at least 24 hours. This prolonged duration is consistent with the standard regulatory guidance for once-daily administration.


Q: What happens if I miss a dose of Accel?

Official documentation describes a process where a missed dose may be taken when remembered, unless it is close to the time for the next scheduled dose, in which case the missed dose is skipped. Following this guidance helps maintain the intended concentration of the drug in your system.


Q: Can Accel be taken long-term?

Yes, Accel is officially approved and intended for standardized, long-term administration. It is used for the chronic management of conditions like elevated blood pressure. Clinical studies have examined the safety profile of the medication over continuous periods of multiple years.


Q: Does Accel interact with alcohol?

Regulatory documents do not specifically prohibit the use of alcohol with Accel. However, since the medicine is used for cardiovascular conditions, general medical guidance often suggests limiting alcohol intake. If there are concerns, official resources describe the importance of transparency regarding concurrent intake.


Q: Is Accel safe for breastfeeding mothers?

Official information indicates that the active ingredient in Accel is known to pass into human breast milk. Regulatory guidance exists that often recommends monitoring the infant or discontinuing breastfeeding while using the medication.


Q: Can I stop taking Accel suddenly?

Studies of discontinuation have shown that blood pressure typically returns slowly to the levels observed before treatment, without evidence of a 'rebound' effect documented. Decisions regarding stopping or changing this medication are clinical matters that require discussion with a healthcare professional.


Q: How does the effectiveness of Accel compare to no treatment, according to the evidence?

Clinical trials found that treatment regimens involving Accel were associated with a measured reduction in systolic and diastolic blood pressure. Research also linked these regimens to lower measured rates of serious cardiovascular events, such as heart attack and stroke, when compared to non-active treatments.


Q: Is Accel considered a controlled substance?

Accel (Amlodipine) is not designated as a controlled substance under the U.S. Controlled Substances Act. Official documentation states it is not classified as a controlled substance and does not identify a potential for abuse or physical dependence.


Q: Does Accel cause weight gain?

Weight gain is listed in regulatory documentation as an uncommon side effect. The very common side effect of swelling (oedema), particularly in the ankles or feet, may cause fluid retention which can lead to weight changes.


Q: Can I take Accel with common over-the-counter pain relievers?

Regulatory documents note a potential interaction with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which includes common pain relievers like ibuprofen. These medications may potentially reduce the expected blood pressure-lowering effect of the drug.


Q: What does the research say about the long-term use of Accel?

Long-term clinical studies involving adult patients have found that the drug is generally well-tolerated. Official data does not report an association between the use of the drug and harmful changes in serum cholesterol or blood glucose levels over extended periods of time.


Q: Is there a generic version of Accel available?

Yes, the active ingredient in Accel, Amlodipine, is available in generic form. Generic versions contain the same active ingredient and are subject to the same strict regulatory standards as the brand-name product.


Q: Are there any specific warnings about driving or operating machinery while taking Accel?

Official safety warnings advise caution when driving or operating machinery, especially when first starting treatment or increasing the dosage. This is due to common side effects like dizziness, fatigue, or drowsiness (somnolence) that may temporarily affect concentration.


Q: Does Accel affect sleep patterns?

Official documents list central nervous system effects such as somnolence (drowsiness) and fatigue, which may occur as possible side effects. If these effects are experienced, they may influence sleep patterns.


Q: Are the side effects of Accel permanent?

Most common side effects, such as headache and dizziness, are described in official safety information as being more common at the beginning of treatment and often subside as the body adjusts. If a side effect is experienced, consulting a professional can provide clarity on its expected duration.


Q: Does taking Accel require any special monitoring or lab tests?

While specific lab tests are not routinely required for all patients, official documentation states that special monitoring or initial low doses are required for certain patient groups, such as those with hepatic (liver) impairment. Regular blood pressure checks are standard during treatment.


Q: Are there any common supplements that should be avoided while taking Accel?

Regulatory documents identify certain supplements that may interact with Accel. For instance, St. John’s Wort is noted as a supplement that may potentially cause the drug to be less effective in the body.


Q: What population groups were included in the main clinical trials for Accel?

The major clinical trials used to establish the drug's effectiveness primarily focused on adult populations. These groups included individuals with chronic elevated blood pressure, those with cardiovascular risk factors, and patients with chronic stable chest discomfort (angina).


Q: Does Accel affect mood or mental clarity?

Official regulatory documents list central nervous system effects such as dizziness and somnolence. Less commonly, regulatory labeling has documented possible side effects involving mood, such as depression or anxiety.


Q: What are the ingredients in Accel besides the main drug substance?

In addition to the active ingredient, Amlodipine besylate, the tablets contain inactive ingredients, also known as pharmaceutical excipients. These substances typically include common components like microcrystalline cellulose, dibasic calcium phosphate anhydrous, sodium starch glycolate, and magnesium stearate, which are necessary for forming the tablet.


Q: Does Accel interact with grapefruit or grapefruit juice?

Official guidelines advise caution regarding the consumption of grapefruit or grapefruit juice. The substance may potentially affect the way the drug is metabolized in the body, which could lead to an increase in its concentration in the bloodstream.


Q: How is Accel eliminated from the body?

Accel is mostly processed and broken down into inactive compounds by the liver. The majority of these inactive compounds (approximately 60%) and a small amount of the original drug are then excreted primarily through the urine.


Q: Why is Accel not suitable for certain age groups?

Regulatory bodies specifically note that the effectiveness and safety of Accel have not been established in children under six years of age. Therefore, based on the current available official data, its use is not recommended for that population.


Q: What is the typical duration of treatment with Accel?

Accel is approved for the chronic management of long-term conditions like hypertension and stable angina. Due to the nature of these conditions, treatment is typically continuous and may last for an extended, indefinite period as determined by a healthcare professional.


Q: Can men and women take the same dose of Accel?

Standard regulatory guidance does not specify different initial or maximum doses based on biological sex. Dosing is primarily determined by age, the specific medical condition being treated, and how the individual patient responds to the medication.


Q: Is there a maximum time someone can stay on Accel?

Regulatory data and long-term clinical trials have not defined a specific maximum duration of use. This indicates that the drug is considered suitable for continuous, chronic use when medically appropriate for the approved conditions.


Q: What is the risk of dependence or addiction with Accel?

The official regulatory labeling does not identify a potential for abuse or physical dependence for this medication. Furthermore, the drug is not classified as a controlled substance.


Q: What should I do if a specific side effect (e.g., headache) gets worse while on Accel?

Official guidance describes the importance of consulting a healthcare professional regarding any side effect. This is recommended particularly if a reaction becomes persistent, highly bothersome, or appears to worsen significantly during the course of treatment.


Q: Is it normal to feel a difference in the first few days of taking Accel?

While the full therapeutic effect takes several weeks to stabilize, some patients may notice certain side effects within the first few days. Official data shows that nervous system effects like dizziness or fatigue are more commonly reported when starting the treatment.

How should Accel be stored and disposed of?

Storage and Disposal Requirements

The storage of Accel (Amlodipine) tablets is strictly defined by regulatory guidance to ensure product stability and integrity.

Storage Requirement Specification
Temperature Store at Controlled Room Temperature (20°C to 25°C), with excursions permitted between 15°C and 30°C.
Protection Protect from moisture; do not store in the bathroom or areas of high humidity.
Container Keep in the original container and ensure it is tightly closed.
Prohibited Do not freeze the tablets.

All medication must be stored out of the sight and reach of children.

For disposal, unused or expired tablets must not be flushed down the toilet or poured into a drain. Disposal should follow official medicine take-back programs or involve mixing the tablets with an undesirable substance and sealing them for household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Accel found in:

A-Z Index: